Skip to main content

Ceres Nets $75M in Private Stock Offering for Biofuel Plant R&D

NEW YORK (GenomeWeb News) - Plant genomics company Ceres has raised $75 million through a private offering of convertible stock led by the private equity firm Warburg Pincus, Ceres said today.
 
Ceres plans to use the funds to develop crops bred to maximize biomass that may be used for biofuels, and for capital expenditures and for corporate purposes.
 
Ceres said its development efforts include biofuel crops such as switchgrass, sorghum, miscanthus, energycane, and woody species.
 
The Thousand Oaks, Calif.-based company said its switchgrass cultivar is scheduled for commercial launch in 2009.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.